Emerging Companies on the Rise
Fortune India’s The Next 500 event showed how emerging companies are scaling new levels.
dr lal pathlabs 2
August 2023
May 2022
May 2019
Dr. Lal Pathlabs shares hit 52-week low post Q4 results; here’s why
Dr. Lal Pathlabs has reported a 27% YoY fall in consolidated net profit to ₹62 crore in Q4FY22 due to a decline in revenue from Covid and allied business.
‘Going public will help build credibility with stakeholders’
By holding itself accountable to committed results and highest governance standards, Metropolis hopes to attract and retain the support of marquee investors for future growth.
